The thermal stability of a monoclonal antibody drug directly impacts its structural integrity, biological activity, and how long it stays effective. Understanding this stability early on is key to choosing the right formulations and advancing the most promising candidates. However, conventional thermal analysis methods — often slow and limited to one sample at a time — can create bottlenecks during early development stages.
Access this application note to explore
- The role of thermal stability in monoclonal antibody development
- How rapid differential scanning calorimetry streamlines antibody stability analysis
- Use cases demonstrating faster, more informative antibody stability screening
